Searchable abstracts of presentations at key conferences in endocrinology

ea0091wa2 | Workshop A: Disorders of the hypothalamus and pituitary | SFEEU2023

Giant prolactinoma requiring surgery

Omer Maria , Panicker Janki

35-year-old lady, has a background of Hypertension, oophorectomies for ovarian cancer and previous 2 IVF attempts, referred to endocrinology with three-week history of blurred vision, bitemporal hemianopia and large pituitary mass on MRI Upon assessment, she reported visual disturbance and intermittent headache. She has no periods which is expected with the history of oophorectomy, but she denied galactorrhoea or any symptoms suggestive of pituitary hormone excess or deficienc...

ea0091wd12 | Workshop D: Disorders of the adrenal gland | SFEEU2023

Primary bilateral macronodular adrenal hyperplasia as a cause for Cushing syndrome

Shamsaldeen Mohammed , Panicker Janki

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause of Cushing’s syndrome and is more often diagnosed as bilateral adrenal incidentalomas with subclinical cortisol production. It is mainly a heterogeneous disease, but familial cases have been reported. Treatment of PBMAH with overt Cushing’s syndrome is usually bilateral adrenalectomy with unilateral adrenalectomy occasionally used to normalize urinary free cortisol (UFC) in patie...

ea0091cb14 | Additional Cases | SFEEU2023

Familial dysalbuminemic hyperthyroxinemia (FDH)

Shamsaldeen Mohammed , Panicker Janki

Introduction: Familial dysalbuminemic hyperthyroxinemia (FDH) is a familial autosomal dominant condition that was first reported in 1979. It is caused by a mutant albumin molecule with an increased affinity for serum thyroxine (T4), despite the serum albumin level being normal. FDH causes increase in total T4 and T3 level with normal TSH level. As FDH patients are clinically euthyroid and asymptomatic, they do not require treatment.Case report: 68-year-o...

ea0094p242 | Neuroendocrinology and Pituitary | SFEBES2023

Uncontrolled primary hypothyroidism causing pituitary hyperplasia and mimicking pituitary adenoma

Hamilton Amanda , Panicker Janki

Pituitary hyperplasia secondary to primary hypothyroidism (PHPH) is a consequence of long term untreated or uncontrolled primary hypothyroidism. The proliferation of thyrotrophs in the pituitary gland, due to the lack of negative feedback on the hypothalamus from low circulating thyroid hormone levels, causes elevated thyroid stimulating hormone (TSH) levels. Hyperprolactinaemia can also be present due to the stimulatory effect of TSH on lactotrophs. Pituitary hyperplasia caus...

ea0094p291 | Thyroid | SFEBES2023

Pembrolizumab Induced Hypothyroidism in a Patient with Pre-existing Thyrotoxicosis due To Grave’s Disease

Grounds Kerrie , Panicker Janki

Thyroid dysfunction by Immune Checkpoint Inhibitors (ICPI) is a common Immune-Related Adverse Event (IRAE). Thyroid dysfunction is prevalent in cancer patients receiving pembrolizumab treatment (ICPI). Most prevalent clinical manifestations are reversible destructive thyroiditis and overt hypothyroidism. Pembrolizumab-induced thyroid IRAE’s have been reported to range from 3.2% to 10.1%.Case report: This case reports a 64-year-old l...

ea0081p2 | Adrenal and Cardiovascular Endocrinology | ECE2022

A rare ARMC5 mutation causing bilateral macronodular adrenal hyperplasia and Cushing’s syndrome

Panicker Janki , Waghorn Alison , Ewins David

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a highly heterogeneous disorder and is the cause of <2% of cases of Cushing’s syndrome. Around 20-25% of patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) have a mutation in ARMC5.Case report: 47 year old gentleman was incidentally found to have bilateral adrenal lesions when he had a CT scan of his chest performed for chest and back pains. He had ...

ea0065p90 | Bone and calcium | SFEBES2019

Rare case of pseudohypoparathyroidism Type 1b

Panicker Janki , Hegde Pallavi , Sharma Dushyant , Purewal Tejpal

Pseudohypoparathyroidism (PHP) is highly heterogeneous rare disorder characterized by end organ resistance to PTH action with proven genetic component. PHP-Ib classically refers to a condition characterized by renal resistance to PTH in the absence of other endocrine or physical abnormalities and in the presence of a normal GNAS alfa activity and only few cases have been reported so far. We report a case of 43 year old gentleman was diagnosed to have seizures at the age of 13 ...

ea0094p287 | Thyroid | SFEBES2023

Using TRAb as a predictor of relapse in Graves’ disease

Lewin Michelle , Grounds Kerrie , Hamilton Amanda , Jones Karen , Panicker Janki

Background: Thyroid stimulating receptor hormone receptor antibodies (TRAb) markers are useful in confirming diagnosis of Graves’ disease, but also recognised as a predictor of relapse. Good practice dictates that a TRAb is measured at the commencement of treatment, to confirm a diagnosis of graves’ disease. Repeating the TRAb before discontinuation of treatment can assist in guiding treatment. If TRAb remains elevated, the chances of relapse are inc...

ea0065p326 | Neuroendocrinology | SFEBES2019

A rare pituitary tumour mimicking an adenoma – spindle cell oncocytoma

Panicker Janki , Hegde Pallavi , Sinha Anubhav , Rati Nitika , Sharma Dushyant , Purewal Tejpal

Spindle cell oncocytoma (SCO) is a rare nonfunctioning neoplasm of the anterior pituitary gland .This tumour is often misdiagnosed as pituitary adenoma or pituitcytoma due to it’s location and symptoms. Such tumours are highly vascular radiologically and histologically. We report a 54 year old gentleman who was found to have pituitary adenoma on CT head performed after a fall. Subsequent Pituitary MRI showed 25×18 mm pituitary macroadenoma with optic chiasm compressi...

ea0086p92 | Neuroendocrinology and Pituitary | SFEBES2022

Natural history of non-functioning pituitary microadenomas – results from the UK NFA consortium

Hamblin Ross , Fountas Athanasios , Lithgow Kirstie , Loughrey Paul Benjamin , Bonanos Efstathios , Khalid Shinwari Shah , Mitchell Kirsten , Shah Syed , Grixti Lydia , Matheou Mike , Isand Kristina , McLaren David , Surya Ashutosh , Zubair Ullah Hafiz , Klaucane Katarina , Jayasuriya Anuradha , Bhatti Sumbal , Mavilakandy Akash , Ahsan Masato , Mathew Susan , Hussein Ziad , Jansz Thijs , Wunna Wunna , Ayuk John , Abraham Prakash , Drake William , Brooke Antonia , Baldeweg Stephanie E. , Sam Amir H. , Martin Niamh , Higham Claire , Reddy Narendra , Ahluwalia Rupa , Newell-Price John , Vamvakopoulos Joannis , Krishnan Amutha , Lansdown Andrew , Murray Robert D , Pal Aparna , Bradley Karin , Mamoojee Yaasir , Purewal Tejpal , Panicker Janki , Marie Freel E , Hasan Faisal , Kumar Mohit , Jose Biju , Hunter Steven , Karavitaki Niki

Background: The published data on the natural history of (presumed) non-functioning pituitary microadenomas (micro-NFAs) is possibly compromised by small sample sizes, short follow-up and inclusion of cases with other pathologies in the analyses.Objective: To clarify the long-term outcomes of micro-NFAs in a large cohort of patients.Methods: We conducted a multi-centre, retrospective, cohort study involving 22 UK endocrine departme...